Rchr
J-GLOBAL ID：200901041528853214   Update date: Apr. 05, 2024

Ohtsu Naoki

オオツ ナオキ | Ohtsu Naoki
Affiliation and department：
University of Tsukuba Laboratory for Stem Cell Therapy, Faculty of Medicine

About University of Tsukuba Laboratory for Stem Cell Therapy, Faculty of Medicine


Job title： Researcher (Concurrent post)
Research field  (4)： Medical biochemistry ,  Developmental biology ,  Cell biology ,  Molecular biology
Research keywords  (7)： Genome editting ,  induced cancer stem cell ,  Eva1 ,  Hematopoietic Stem Cell ,  glioma-initiating cell, GIC ,  Glioblastoma multiforme, GBM ,  Hematopoiesis
Research theme for competitive and other funds  (9)：
  • 2018 - 2021 Establishment of Eva1 positive Glioma Stem Cell Suppression system using Genome Editing
  • 2016 - 2018 Chemical Screening of RelB-NF-kB Signal Inhibitor in Glioblastoma-Initiating Cells
  • 2011 - 2012 Functional analysis of HIPK family genes in hematopoiesis derived from hemogenic endothelial cells and mesodermal cells
  • 2011 - 2012 Functional analysis of HIPK2 in the differentiation of vascular endothelial progenitor cell into hematopoietic stem cells
  • 2011 - 2012 Effect of nsPEF and IBSEFin hematopoietic cell differentiation
Show all
Papers (10)：
ｍore...
MISC (8)：
ｍore...
Lectures and oral presentations  (8)：
  • Cross-species transmission of;rat hepacivirus;its adaptation to mouse
    (The Japanese Society for Virology 2021)
  • Eva1 maintains the characteristics of glioblastoma-initiating cells through the activation of non-canonical NF-kB signaling pathway
    (Keystone Symposia , Stem Cells and Cancer 2016)
  • Eva1 enhance the formation and development of gliomas in mouse and human
    (BMB2015 Biochemistry and Molecular Biology 2015)
  • Inhibitory Effects of Homeodomain-Interacting Protein Kinase 2 on the Aorta-Gonad-Mesonephros Hematopoiesis
    (The 20th IUBMB International Congress of Biochemistry and Molecular Biology and the 11th FAOBMB Congress 2006)
  • HIPK2 による胎生期造血発生抑制機構の解析
    (第35回日本免疫学会年会 2005)
ｍore...
Education (3)：
  • 2003 - 2007 Kumamoto University Graduate school of medical science
  • 2001 - 2003 Kumamoto University Graduate School of Science and Technology Department of Systems in Natural Environment
  • 1997 - 2001 Kumamoto University Faculty of Science Department of biological science
Professional career (1)：
  • Ph.D. (Kumamoto University)
Work history (7)：
  • 2024/04 - 現在 University of Tsukuba Laboratory for Stem Cell Therapy Research (Concurrent post)
  • 2023/04 - 現在 Celaid Theraputics Inc. Research and Development Division Chief Researcher
  • 2021/04 - 2023/03 University of Yamanashi Graduate School of Medicine Project Research Associate
  • 2015/04 - 2021/03 Institute for Genetic Medicine, Hokkaido University Division of Stem Cell Biology Assistant Proffesor
  • 2012/04 - 2015/03 Institute fot Genetic Medicine, Hokkaido University Division of Stem Cell Biology Postdoctoral Fellow
Show all
Awards (2)：
  • 2017/07 - Institute of Medicine, Hokkaido University Azuma Ichito Fund
  • 2017/07 - 2nd International conference on Tumor & Cancer Immunology and Immunotherapy Best Poster Award Inhibition of Eva1 degrade the formation and development of glioblastomas
Association Membership(s) (2)：
Japanese cancer associate ,  The Molecular Biology Society of Japan
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM